Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Kestra Medical Technologies, Ltd. (KMTS) had Stock-Based Compensation of $13.23M for the most recently reported fiscal quarter, ending 2025-10-31.
| Income Statement Financials | |
$22.57M |
|
$-32.78M |
|
$11.14M |
|
$11.42M |
|
$54.32M |
|
$-31.75M |
|
$-1.00M |
|
$-32.75M |
|
$-32.75M |
|
$-32.78M |
|
$-32.78M |
|
$-32.78M |
|
$-32.78M |
|
$-31.75M |
|
$-28.91M |
|
51.38M |
|
51.38M |
|
$-0.64 |
|
$-0.64 |
|
| Balance Sheet Financials | |
$195.41M |
|
$45.93M |
|
$51.29M |
|
$246.70M |
|
$35.76M |
|
$41.87M |
|
$46.86M |
|
$82.62M |
|
$164.08M |
|
$164.08M |
|
$164.08M |
|
51.45M |
|
| Cash Flow Statement Financials | |
$-44.62M |
|
$-15.65M |
|
$-1.90M |
|
$237.93M |
|
$175.76M |
|
$-62.17M |
|
|
Stock-Based Compensation |
$13.23M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.47 |
|
-- |
|
-- |
|
0.20 |
|
0.26 |
|
50.63% |
|
-140.73% |
|
-140.73% |
|
-- |
|
-145.14% |
|
-145.29% |
|
$-60.27M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
-- |
|
2.17 |
|
41.53 |
|
-19.98% |
|
-19.98% |
|
-13.29% |
|
-15.92% |
|
$3.19 |
|
$-1.17 |
|
$-0.87 |
|